Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Targa Resources Inc. Common Stock (TRGP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Targa Resources Inc. Common Stock — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Targa Resources Inc. Common Stock trades at $290.9 (market cap $62.84B). The key difference: Targa Resources Inc. Common Stock is far larger — about 64.6× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Targa Resources Inc. Common Stock pays a 1.71% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Targa Resources Inc. Common Stock for 5 Days on average.
| MRVI | TRGP | |
|---|---|---|
Market Cap | $972.90M | $62.84B |
Volume | 4,325,710 | 654,800 |
Sector | Health | Energy |
52-Week High | $9.00 | $302.25 |
52-Week Low | $2.83 | $146.30 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $1.08B | $82.28B |
Dividend Yield | — | 1.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
TRGP trades at $293.04, up 0.86% today, with a bullish technical signal driven by moving averages and a consensus analyst price target of $329.54. The company reported strong Q2 2026 EPS of $3.54, beating expectations, and maintains robust profitability with a net income margin of 13.54% and ROE of 72.27%. Recent news highlights a $1.25 quarterly dividend and sustainability reporting, reflecting stable operations.
The outlook is positive given earnings beats, high analyst buy ratings (82%), and projected revenue growth, though risks include commodity price exposure and high debt-to-asset ratio of 68.07%. The stock's current price near the analyst low target of $294.00 suggests potential upside if fundamentals hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Targa Resources Inc. Common Stock
Targa Resources provides midstream infrastructure for natural gas and natural gas liquids. Its services include gathering, processing, transportation, fractionation, storage, and export logistics.
Read more on TRGP →
